In a discovery that could have practical implications both for developing pain drugs and treatments for neuroinflammatory diseases, scientists have identified an enzyme that contributes to the production of pro-inflammatory prostaglandins in the brain, lung and liver, but not in the gut or heart.The discovery, senior author Benjamin Cravatt told BioWorld Today, is in some ways reminiscent of the discovery of cyclooxygenase 2 (COX2).